Health and Fitness Health and Fitness
Mon, December 12, 2011
[ Mon, Dec 12th 2011 ] - Market Wire
Abiomed 2011 Investor Day Webcast Replay Available
[ Mon, Dec 12th 2011 ] - Market Wire
First FDA-Approved Treatment for Myelofibrosis, J .. ssed in Multiple Presentations at 2011 ASH Annual
[ Mon, Dec 12th 2011 ] - Market Wire
Paladin Labs Announces the Canadian Launch of DigiFab(TM) Digoxin Immune Fab (Ovine)
[ Mon, Dec 12th 2011 ] - Market Wire
Lilly Oncology Reveals Findings From Study of JAK2 Inhibitor for Blood Cancers at ASH Meeting
[ Mon, Dec 12th 2011 ] - Market Wire
Community Health Systems Announces Definitive Agreement to Acquire Blue Island, Illinois Hospital
[ Mon, Dec 12th 2011 ] - Market Wire
AMAG Pharmaceuticals Announces Preliminary Data R .. acy of a Single Infusion of 1020 mg Ferumoxytol (
[ Mon, Dec 12th 2011 ] - Market Wire
Nektar Therapeutics Initiates Phase 3 BEACON Tria .. f NKTR-102 in Women with Metastatic Breast Cancer
[ Mon, Dec 12th 2011 ] - Market Wire
ProMetic Announces Achievement of Significant Targeted Milestone With a Multinational Company
[ Mon, Dec 12th 2011 ] - Market Wire
PDL BioPharma Announces Departure of Chief Financial Officer
[ Mon, Dec 12th 2011 ] - Market Wire
Mylan Names John Thievon President of Dey Pharma
[ Mon, Dec 12th 2011 ] - Market Wire
Soligenix Announces Publication of Results of its .. al Trial of orBec in the Prevention of Acute GVHD
[ Mon, Dec 12th 2011 ] - Market Wire
MELA Sciences Announces Additions to Board of Directors
[ Mon, Dec 12th 2011 ] - Market Wire
Emergent BioSolutions to Participate in January 2012 Investor Conferences
[ Mon, Dec 12th 2011 ] - Market Wire
PDL BioPharma Corrects Its Adjusted Conversion Rates for Its Convertible Notes
[ Mon, Dec 12th 2011 ] - Market Wire
Kraig Biocraft Laboratories Receives New Custom Z .. er Configurations for Advanced Fibers Development
[ Mon, Dec 12th 2011 ] - Market Wire
Abbott and Reata Pharmaceuticals Announce Agreeme .. ze Next-Generation Antioxidant Inflammation Modul
[ Mon, Dec 12th 2011 ] - Market Wire
10-Year Study Demonstrates IRIDEX MicroPulsea" La .. ffective for Patients with Diabetic Macular Edema
[ Mon, Dec 12th 2011 ] - Market Wire
Inovio Pharmaceuticals to Present at Oppenheimer Investor Conference
Sun, December 11, 2011
[ Sun, Dec 11th 2011 ] - Market Wire
Pharming granted U.S. patent on C1 inhibitor use in ischemia reperfusion injury indications
[ Sun, Dec 11th 2011 ] - Market Wire
Onyx Pharmaceuticals Announces FDA Standard Revie .. New Drug Application for the Treatment of Relapse
Sat, December 10, 2011
[ Sat, Dec 10th 2011 ] - Market Wire
Onyx Pharmaceuticals Provides Update on Carfilzom .. 3rd American Society of Hematology Annual Meeting
[ Sat, Dec 10th 2011 ] - Market Wire
Brower Piven Encourages Investors Who Have Losses .. nvestment in Pain Therapeutics, Inc. to Inquire A
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;; u
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir,;;;
[ Sat, Dec 10th 2011 ] - Market Wire
Abiomed Announces Expanded Heart Recovery Strategy with Multi Year Growth Initiatives
[ Sat, Dec 10th 2011 ] - Market Wire
Exact Sciences Announces Successful Completion of Public Offering of Common Stock
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead maakt tweejaarsgegevens bekend van crucial .. ie van elvitegravir, een integraseremmer voor hiv
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead gibt Zweijahresdaten der Phase-3-Pivotstud .. itegravir, einem Integrasehemmer bei HIV, bekannt
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead annuncia i dati raccolti in due anni nella .. le di Fase III su elvitegravir, un inibitore dell
[ Sat, Dec 10th 2011 ] - Market Wire
Data Shows Medtronic AdaptiveStima" with RestoreSensora" Provides Pain Relief and Convenience
[ Sat, Dec 10th 2011 ] - Market Wire
Gilead Announces Two-Year Data From Pivotal Phase .. y of Elvitegravir, an Integrase Inhibitor for HIV
Fri, December 9, 2011
[ Fri, Dec 09th 2011 ] - Market Wire
Kahn Swick & Foti, LLC Announces Investigation in .. Report of Possible Federal Manufacturing Suspens
[ Fri, Dec 09th 2011 ] - Market Wire
Amgen to Present at the 22nd Annual Oppenheimer Healthcare Conference
[ Fri, Dec 09th 2011 ] - Market Wire
Shengtai Pharmaceutical, Inc. Announces Annual Meeting Date
[ Fri, Dec 09th 2011 ] - Market Wire
Thoratec Presentation at Oppenheimer Conference to Be Webcast
[ Fri, Dec 09th 2011 ] - Market Wire
HeartWare to Present at the Oppenheimer 22nd Annual Healthcare Conference
[ Fri, Dec 09th 2011 ] - Market Wire
Quest Diagnostics Care360a" Named Top e-Prescribing Platform by Black Book Rankings
[ Fri, Dec 09th 2011 ] - Market Wire
Lilly for Better Healtha" Expands Website to Incl .. Spanish Health Information and Interactive Tools
[ Fri, Dec 09th 2011 ] - Market Wire
AVI BioPharma Names Jayant Aphale, Ph.D., Senior Vice President of Technical Operations
[ Fri, Dec 09th 2011 ] - Market Wire
VentriPoint Announces Proposed Issuance of Shares for Debt and Credit Facility
[ Fri, Dec 09th 2011 ] - Market Wire
Edwards Lifesciences Forecasts Strong Sales and Earnings Growth in 2012
[ Fri, Dec 09th 2011 ] - Market Wire
CytoSorbents Announces Purchase Agreement for up to $8.5 Million With Lincoln Park Capital
[ Fri, Dec 09th 2011 ] - Market Wire
ULURU Inc. Receives Notice From NYSE Amex Regarding Continued Listing Standards
[ Fri, Dec 09th 2011 ] - Market Wire
BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
[ Fri, Dec 09th 2011 ] - Market Wire
Smart-Tek Solutions, Inc. Projects Recoup and Possible Loss Exceeded by 4th Quarter's End
[ Fri, Dec 09th 2011 ] - Market Wire
Mindray Medical to Acquire a Controlling Stake in Zhejiang Greenlander Information Technology
[ Fri, Dec 09th 2011 ] - Market Wire
Aeterna Zentaris Presents Positive Preclinical Da .. 131, a Highly Selective Erk 1/2 Inhibitor, at San
[ Fri, Dec 09th 2011 ] - Market Wire
Hansen Medical Secures $30 Million Debt Facility
[ Fri, Dec 09th 2011 ] - Market Wire
OncoSec to Present at the 22nd Annual Oppenheimer Healthcare Conference
Thu, December 8, 2011
[ Thu, Dec 08th 2011 ] - Market Wire
Transcept Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
[ Thu, Dec 08th 2011 ] - Market Wire
Universal Health Services, Inc. to Present at the Oppenheimer 22nd Annual Healthcare Conference
[ Thu, Dec 08th 2011 ] - Market Wire
Lpath Files Registration Statement to Raise up to $10 Million
[ Thu, Dec 08th 2011 ] - Market Wire
China's Booming Healthcare Sector Poised to Benefit China Medical Technologies and Sinovac Biotech
[ Thu, Dec 08th 2011 ] - Market Wire
Nektar Reports Affymax Announced FDA Advisory Com .. fit/Risk Profile for Peginesatide for Treatment o
[ Thu, Dec 08th 2011 ] - Market Wire
SEQUEL Trial Results for Qnexa Published in AJCN Show 10% Sustained Weight Loss Over 2 Years
[ Thu, Dec 08th 2011 ] - Market Wire
Bionovo Announces the Publication of its Tissue S .. en Receptor Modulators for Postmenopausal Obesity
[ Thu, Dec 08th 2011 ] - Market Wire
WeedMaps Acquires Android Application WeedLaws
[ Thu, Dec 08th 2011 ] - Market Wire
Arena Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference
[ Thu, Dec 08th 2011 ] - Market Wire
Genomic Health Announces Positive Results of Firs .. Biomarker Discovery Using Next Generation Sequen
[ Thu, Dec 08th 2011 ] - Market Wire
Coronado Biosciences Announces Phase 1 Results of .. e Presented at the American Society of Hematology
[ Thu, Dec 08th 2011 ] - Market Wire
Shire Reports Positive Phase II Results for Inves .. nse (lisdexamfetamine dimesylate) Capsules, (CII)
[ Thu, Dec 08th 2011 ] - Market Wire
Auxilium Pharmaceuticals, Inc. Appoints Adrian Adams Chief Executive Officer and President
[ Thu, Dec 08th 2011 ] - Market Wire
Isis Pharmaceuticals Holds Webcast to Discuss Recent Additions to its Development Pipeline
[ Thu, Dec 08th 2011 ] - Market Wire
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
[ Thu, Dec 08th 2011 ] - Market Wire
Neurologist Survey Confirms Need for Improved Adm .. ation of Parkinson's Disease Acute Rescue Therapy
[ Thu, Dec 08th 2011 ] - Market Wire
Kraig Biocraft Laboratories Announces Filing of I .. on for Spider-Silk and Transgenic Silkworm Techno
[ Thu, Dec 08th 2011 ] - Market Wire
Cord Blood America CEO Matthew Schissler Intervie .. nancial Performance, Stock Price, 2012 Strategies
Wed, December 7, 2011
[ Wed, Dec 07th 2011 ] - Market Wire
Allon Shareholders Approve Balance of October Prospectus Financing
[ Wed, Dec 07th 2011 ] - Market Wire
Lakeland Industries, Inc. Reports Third Quarter Fiscal Year 2012 Financial Results
[ Wed, Dec 07th 2011 ] - Market Wire
International Drug &;; Explosives Detec .. Signs Marketing Agreement With Company From China
[ Wed, Dec 07th 2011 ] - Market Wire
Leading Investigator to Present Clinical Data on .. ternational Diabetes Federation Meetings in Dubai
[ Wed, Dec 07th 2011 ] - Market Wire
VistaGen Therapeutics and Synterys Sign Strategic .. Chemistry Collaboration Agreement for Drug Rescue
[ Wed, Dec 07th 2011 ] - Market Wire
Aoxing Pharmaceutical Company Announces $3.2 Million Financing
[ Wed, Dec 07th 2011 ] - Market Wire
Novelos Therapeutics Closes $6 Million Public Offering
[ Wed, Dec 07th 2011 ] - Market Wire
MuGard Advocate Interviewed on ABC Tampa News at Noon
[ Wed, Dec 07th 2011 ] - Market Wire
Theratechnologies to Discontinue COPD Clinical Program and Accelerate Path to Profitability
[ Wed, Dec 07th 2011 ] - Market Wire
InterMune to Present at Oppenheimer & Co. 22nd Annual Healthcare Conference on Dec. 14
[ Wed, Dec 07th 2011 ] - Market Wire
Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
[ Wed, Dec 07th 2011 ] - Market Wire
PROLOR Biotech to Present at Oppenheimer 22nd Annual Healthcare Conference
[ Wed, Dec 07th 2011 ] - Market Wire
Stem Cell Therapeutics Announces Reorganization and Management Changes
[ Wed, Dec 07th 2011 ] - Market Wire
Jules Musing to Lead Business Development Effort
[ Wed, Dec 07th 2011 ] - Market Wire
Weight Loss and Effects on Diabetes with Qnexa Tr .. Results Presented at the World Diabetes Congress
[ Wed, Dec 07th 2011 ] - Market Wire
Uroplasty to Present at the Oppenheimer 22nd Annual Healthcare Conference
[ Wed, Dec 07th 2011 ] - Market Wire
Inovio Pharmaceuticals Closes $4.0 Million Underwritten Financing
Tue, December 6, 2011
[ Tue, Dec 06th 2011 ] - Market Wire
Humana Inc. to Present at the Oppenheimer 22nd Annual Healthcare Conference
[ Tue, Dec 06th 2011 ] - Market Wire
Genomic Health Announces Positive Study Results V .. in DCIS Breast Cancer at the 2011 CTRC-AACR San A
[ Tue, Dec 06th 2011 ] - Market Wire
Ergoresearch Announces the Appointment of Its New .. evelopment and Grants Stock Options to Its Vice-P
[ Tue, Dec 06th 2011 ] - Market Wire
China Medical Technologies Responds to the Allegations Raised by Glaucus Research Group
[ Tue, Dec 06th 2011 ] - Market Wire
Quest Diagnostics Launches Simplexaa" Dengue Test .. Molecular Test Approved for Nation's Public and P
[ Tue, Dec 06th 2011 ] - Market Wire
Pharmathene Announces Publication of Phase I Study Results for Anthrax Anti-toxin Valortim
[ Tue, Dec 06th 2011 ] - Market Wire
The Special Committee of Helix BioPharma Corp. Provides Update to Shareholders
[ Tue, Dec 06th 2011 ] - Market Wire
Aethlon Medical Announces Approval and Initiation .. Research Study to Target Tumor-Secreted Exosomes
[ Tue, Dec 06th 2011 ] - Market Wire
MissionIR Features VistaGen Therapeutics in Exclusive Interview Featuring CEO Shawn Singh
[ Tue, Dec 06th 2011 ] - Market Wire
Avanir Pharmaceuticals Announces Date of Fiscal 2 .. nd Year End Financial Results and Conference Call
[ Tue, Dec 06th 2011 ] - Market Wire
New Study Shows AFECTAIR Significantly Improved D .. e Under Simulated Neonatal Ventilatory Conditions
[ Tue, Dec 06th 2011 ] - Market Wire
Isis Reports Positive Phase 1 Data Demonstrating .. ificant Reductions in apoC-III Protein Levels and
[ Tue, Dec 06th 2011 ] - Market Wire
Varian Medical Systems Adds High Dose Delivery an .. bilities to Clinac and Trilogy Cancer Treatment M
[ Tue, Dec 06th 2011 ] - Market Wire
Data Suggest Optimer's DIFICID Provides Economic .. ment of Clostridium difficile-associated Diarrhea
[ Tue, Dec 06th 2011 ] - Market Wire
Peregrine's Bavituximab Shows 50% Improvement in .. nse Rate in Randomized Phase II Lung Cancer Trial
[ Tue, Dec 06th 2011 ] - Market Wire
Paradigm Business Update as of November 30, 2011
[ Tue, Dec 06th 2011 ] - Market Wire
BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
Mon, December 5, 2011
[ Mon, Dec 05th 2011 ] - Market Wire
Titan Medical Inc. Announces Memorandum of Unders .. h India Based Apollo Hospitals Enterprise Limited
[ Mon, Dec 05th 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. Securities Laws Violations by Pacific Biosciences
[ Mon, Dec 05th 2011 ] - Market Wire
MiMedx Group Receives HCPCS C-Code from Medicare for EpiFix Reimbursement
[ Mon, Dec 05th 2011 ] - Market Wire
Asantae Announces a New Website, Affiliate Back Office and Compensation Plan
[ Mon, Dec 05th 2011 ] - Market Wire
diaDexus, Inc. to Present at the Canaccord Genuity Healthcare Conference
[ Mon, Dec 05th 2011 ] - Market Wire
DiaMedica's DM-199 for Type 1 Diabetes Significan .. and Demonstrates a Dramatic Increase in C-Peptide
[ Mon, Dec 05th 2011 ] - Market Wire
Exelixis and Cardium on the Rise as Biotechnology Industry Stays Strong in Volatile Market
[ Mon, Dec 05th 2011 ] - Market Wire
The Medicines Company Invests Equity Stake in GeN .. LLC, Nitric Oxide Delivery and Technology Company
[ Mon, Dec 05th 2011 ] - Market Wire
Peregrine to Report Second Quarter Fiscal Year 20 .. nancial Results After Market on December 12, 2011
[ Mon, Dec 05th 2011 ] - Market Wire
CareFusion Showcases Medication Management Techno .. Society for Health-System Pharmacists Conference
[ Mon, Dec 05th 2011 ] - Market Wire
Sun Healthcare Group, Inc. Pursues Amendment to Its Senior Secured Credit Facility
[ Mon, Dec 05th 2011 ] - Market Wire
Horizon Pharma Announces Launch of DUEXIS(R) (Ibu .. n/Famotidine) 800 mg/26.6 mg in the United States
[ Mon, Dec 05th 2011 ] - Market Wire
Avanafil Data Presented at the European Society of Sexual Medicine Meeting
[ Mon, Dec 05th 2011 ] - Market Wire
Concord Medical Completes its Twelfth Annual Academic Conference
[ Mon, Dec 05th 2011 ] - Market Wire
New Data Demonstrating the Impact of Opioid-Relat .. spital Cost Presented at American Society of Heal
[ Mon, Dec 05th 2011 ] - Market Wire
Radient Pharmaceuticals' Two Abstracts Submitted .. cers Symposium (ASCO) Regarding Onko-Sure Utility
[ Mon, Dec 05th 2011 ] - Market Wire
68% of Healthcare Workers Believe Needlestick Inj .. blem According to a MedPro Safety Products Survey
Sun, December 4, 2011
[ Sun, Dec 04th 2011 ] - Market Wire
Two Year Results of Phase 3 Studies with EYLEAa" .. t AMD Show Sustained Improvement in Visual Acuity
Fri, December 2, 2011
[ Fri, Dec 02nd 2011 ] - Market Wire
Cigna International Expatriate Benefits Expande Rede de Atendimento de Sade no Brasil
[ Fri, Dec 02nd 2011 ] - Market Wire
Rigrodsky & Long, P.A. Announces Its Investigatio .. he Federal Securities Laws by Pacific Biosciences
[ Fri, Dec 02nd 2011 ] - Market Wire
Pfizer Completes Acquisition of Excaliard
[ Fri, Dec 02nd 2011 ] - Market Wire
MDxHealth Enters Agreement with Celldex for Use o .. t in Phase III Rindopepimut Study in Brain Cancer
[ Fri, Dec 02nd 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky Launches an Inve .. ches of Fiduciary Duties and Unjust Enrichment by
[ Fri, Dec 02nd 2011 ] - Market Wire
Synergetics USA Announces Conference Call to Review First Quarter of Fiscal Year 2012 Results
[ Fri, Dec 02nd 2011 ] - Market Wire
Graymark Healthcare Signs Milestone 100th Sleep Center Agreement
[ Fri, Dec 02nd 2011 ] - Market Wire
Skilled Healthcare Group to Present at the Oppenh .. Annual Healthcare Conference on December 13, 2011
[ Fri, Dec 02nd 2011 ] - Market Wire
CareFusion Launches Wireless Diagnostic and Monitoring Neurological Device
[ Fri, Dec 02nd 2011 ] - Market Wire
Concord Medical Announces Shareholder Resolutions .. ual General Meeting, Board and Management Changes
[ Fri, Dec 02nd 2011 ] - Market Wire
Trimel Pharmaceuticals Corporation Manufacturing Facility Receives GMP Compliance Designation
[ Fri, Dec 02nd 2011 ] - Market Wire
Medivir - TMC435 Will Be Evaluated in a Phase II .. latasvir (BMS 790052) for HCV Genotype-1 Patients
[ Fri, Dec 02nd 2011 ] - Market Wire
Mylan Launches Generic Version of Cyklokapron Injection
[ Fri, Dec 02nd 2011 ] - Market Wire
Oncolytics Biotech Inc. Announces Phase 2 Clinica .. ation with Gemcitabine in Pancreatic Cancer Reach
[ Fri, Dec 02nd 2011 ] - Market Wire
The Ensign Group Acquires Colorado Home Health Company
[ Fri, Dec 02nd 2011 ] - Market Wire
Kraig Biocraft Laboratories to Host Shareholder C .. duct, Scientific and Commercialization Developmen
[ Fri, Dec 02nd 2011 ] - Market Wire
Pharmacyclics Appoints Chief Medical Officer Dr. Lori Anne Kunkel
Thu, December 1, 2011
[ Thu, Dec 01st 2011 ] - Market Wire
MiMedx Group, Inc. to Present at the 6th Annual C .. ar, Aesthetics and Metabolic Disorders Conference
[ Thu, Dec 01st 2011 ] - Market Wire
Biodel to Report Fourth Quarter Fiscal Year 2011 Financial Results on December 6, 2011
[ Thu, Dec 01st 2011 ] - Market Wire
Brower Piven Encourages Investors Who Have Losses .. nvestment in The Copper Companies, Inc. to Inquir
[ Thu, Dec 01st 2011 ] - Market Wire
Direction of Market Influences - Report Highlights Abbott Laboratories and Novartis AG (ADR)
[ Thu, Dec 01st 2011 ] - Market Wire
DiaMedica's DM-204 for Type 2 Diabetes Significan .. od Glucose, Blood Pressure and Cholesterol Levels
[ Thu, Dec 01st 2011 ] - Market Wire
ADVENTRX Meets with FDA to Discuss Development Plans for ANX-188
[ Thu, Dec 01st 2011 ] - Market Wire
Drug Candidates From Alexza and BioSante Pharmaceuticals Inch Closer to Decision Day
[ Thu, Dec 01st 2011 ] - Market Wire
Lead Drug Candidates From Galena Biopharma and Ar .. a Pharmaceuticals Look to Make Big Splash in 2012
[ Thu, Dec 01st 2011 ] - Market Wire
Mylan Confirms First-to-File Patent Challenge Relating to Generessa" Fe
[ Thu, Dec 01st 2011 ] - Market Wire
Mylan Launches Generic Version of Caduet Tablets
[ Thu, Dec 01st 2011 ] - Market Wire
Stellar to Acquire Tribute Pharmaceuticals to Cre .. r North American Specialty Pharmaceutical Company
[ Thu, Dec 01st 2011 ] - Market Wire
MedCath Announces Sale of Ownership Interest in Harlingen Medical Center and HMC Realty, LLC
[ Thu, Dec 01st 2011 ] - Market Wire
Mylan Committed to Expanding Access in Developing .. es to High Quality, Affordable HIV/AIDS Treatment
[ Thu, Dec 01st 2011 ] - Market Wire
Auxilium Pharmaceuticals, Inc. Announces First Pa .. sed in XIAFLEX Study for Frozen Shoulder Syndrome
[ Thu, Dec 01st 2011 ] - Market Wire
Ceregene Completes Enrollment of Second Phase 2 S .. CERE-120 for the Treatment of Parkinson's Disease
[ Thu, Dec 01st 2011 ] - Market Wire
Titan Pharmaceuticals Confirms Regulatory Guidance for Probuphine
[ Thu, Dec 01st 2011 ] - Market Wire
VIVUS to Present at the Deutsche Bank BioFEST Conference
Wed, November 30, 2011
[ Wed, Nov 30th 2011 ] - Market Wire
Universal Health Services, Inc. Announces Agreement to Acquire Knapp Medical Center
[ Wed, Nov 30th 2011 ] - Market Wire
Uroplasty to Present at the Canaccord Genuity 6th .. etics & Metabolic Disorders Medical Device Confer
[ Wed, Nov 30th 2011 ] - Market Wire
Sunrise Senior Living Celebrates 30th Anniversary
[ Wed, Nov 30th 2011 ] - Market Wire
Novadaq and KCI Sign Commercialization Agreements for the SPY System
[ Wed, Nov 30th 2011 ] - Market Wire
BIOLASE Issued Broad New Patent for Treating Eye .. ons, Including Presbyopia, Cataracts and Glaucoma
[ Wed, Nov 30th 2011 ] - Market Wire
Analytical Reports on Celgene Corporation and Bio .. flux of New Products and Uses in Biotech Industry
[ Wed, Nov 30th 2011 ] - Market Wire
Cytokinetics Announces Positive Results From Phas .. g CK-2017357 in Patients With Amyotrophic Lateral
[ Wed, Nov 30th 2011 ] - Market Wire
ProMetic Provides Update on Its Plasma-Derived Pr .. enture With China National Biotech Group ("CNBG")
[ Wed, Nov 30th 2011 ] - Market Wire
United States Patent and Trademark Office Upholds .. Patents in Two Re-Examination Cases Brought by Is
[ Wed, Nov 30th 2011 ] - Market Wire
Omeros Announces It Has Unlocked Over 20 Percent of Class A Orphan GPCRs
[ Wed, Nov 30th 2011 ] - Market Wire
FONAR Sells UPRIGHT Multi-Position MRI Scanner to .. hased Dynamic Weight-Bearing Multi-Position MRI T
[ Wed, Nov 30th 2011 ] - Market Wire
Curis Announces Agreement with The Leukemia & Lym .. evelop CUDC-907 for Lymphoma and Multiple Myeloma
[ Wed, Nov 30th 2011 ] - Market Wire
Compugen Presents Predictive Drug Target Discovery Platform at European Antibody Conference
[ Wed, Nov 30th 2011 ] - Market Wire
Soliris (culizumab) obtient une autorisation de m .. ur le traitement des patients atteints du syndrom
[ Wed, Nov 30th 2011 ] - Market Wire
Positive Clinical Study Results Reported by Adeona's Oral Zinc for ALS Collaborator
[ Wed, Nov 30th 2011 ] - Market Wire
Astex Pharmaceuticals to Present at World Epigenetics Summit on December 8th
[ Wed, Nov 30th 2011 ] - Market Wire
Watson Launches Generic LIPITOR
Tue, November 29, 2011
[ Tue, Nov 29th 2011 ] - Market Wire
Natural Alternatives International, Inc. Announce .. Beta-Alanine Patent Protecting CarnoSyn Products
[ Tue, Nov 29th 2011 ] - Market Wire
NeuroMetrix to Present at Canaccord Genuity 6th A .. ular, Aesthetics & Metabolic Disorders Conference
[ Tue, Nov 29th 2011 ] - Market Wire
EnteroMedics to Present at the Canaccord Genuity .. ar, Aesthetics and Metabolic Disorders Conference
[ Tue, Nov 29th 2011 ] - Market Wire
WeedMaps Announces Acquisition of Domain Name Marijuana.com
[ Tue, Nov 29th 2011 ] - Market Wire
FDA Accepts ELIQUIS (apixaban) New Drug Applicati .. ion of Stroke and Systemic Embolism in Patients w
[ Tue, Nov 29th 2011 ] - Market Wire
Warnex Announces Resignation of Its President &;; CEO
[ Tue, Nov 29th 2011 ] - Market Wire
Horizon Pharma Announces U.S. Food and Drug Admin .. RA(R) New Drug Application for Review for the Tre
[ Tue, Nov 29th 2011 ] - Market Wire
Warnex Closes Transactions to Amend the Terms of .. ing Debentures and to Obtain Additional Financing
[ Tue, Nov 29th 2011 ] - Market Wire
Compugen and DiscoveRx Form Collaboration to Comm .. alize Novel Peptide Ligands for GPCR Drug Targets
[ Tue, Nov 29th 2011 ] - Market Wire
Omeros Announces Submission to European Medicines .. ic Investigation Plan Letter of Intent for OMS302
[ Tue, Nov 29th 2011 ] - Market Wire
Inhibitex Reports Recent Clinical and Corporate Developments
[ Tue, Nov 29th 2011 ] - Market Wire
Salix Pharmaceuticals to Present at Oppenheimer Healthcare Conference
[ Tue, Nov 29th 2011 ] - Market Wire
ONGLYZA (saxagliptina) aprobado para su utilizaci .. combinacin con insulina (con o sin metformina) en
[ Tue, Nov 29th 2011 ] - Market Wire
Radient Pharmaceuticals Corporation Completes Res .. al Investors to Limit Conversions and Stock Sales
[ Tue, Nov 29th 2011 ] - Market Wire
Exelixis Announces Webcast of Annual R&D Day on This Thursday, December 1
[ Tue, Nov 29th 2011 ] - Market Wire
Perceptive Informatics DataLabs EDC Solution Ranks Highest in Overall Satisfaction
[ Tue, Nov 29th 2011 ] - Market Wire
Threshold Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
Mon, November 28, 2011
[ Mon, Nov 28th 2011 ] - Market Wire
FMX Ventures Inc. Announces Posting of Filing Sta .. ement and Receipt of Conditional Listing Approval
[ Mon, Nov 28th 2011 ] - Market Wire
WSPR Szczecin, Largest Polish EMS Agency Adds ZOL .. rated Automated Compression-Defibrillation System
[ Mon, Nov 28th 2011 ] - Market Wire
Brower Piven Encourages Investors Who Have Losses .. nvestment in Hospira, Inc. to Inquire About the L
[ Mon, Nov 28th 2011 ] - Market Wire
Gentiva Health Services Announces Credit Agreement Amendment
[ Mon, Nov 28th 2011 ] - Market Wire
Paladin Announces Agreement for Novel OTC Product to Prevent Travellers' Diarrhea
[ Mon, Nov 28th 2011 ] - Market Wire
Gilman Law LLP Announces Securities Fraud Lawsuit Against Hospira, Inc.
[ Mon, Nov 28th 2011 ] - Market Wire
AspenBio Reports Data From AppyScore Pilot Study and Planned Product Pathway
[ Mon, Nov 28th 2011 ] - Market Wire
Qualitest Pharmaceuticals Receives FDA Approval f .. gestrel and Ethinyl Estradiol Tablets, USP), 0.05
[ Mon, Nov 28th 2011 ] - Market Wire
Human Genome Sciences Invites Investors to Listen .. bcast of Presentation at Piper Jaffray Conference

Peregrine to Report Second Quarter Fiscal Year 2012 Financial Results After Market on December 12, 2011


//health-fitness.news-articles.net/content/2011/ .. al-results-after-market-on-december-12-2011.html
Published in Health and Fitness on Monday, December 5th 2011 at 5:08 GMT by Market Wire   Print publication without navigation


December 05, 2011 08:00 ET

Peregrine to Report Second Quarter Fiscal Year 2012 Financial Results After Market on December 12, 2011

TUSTIN, CA--(Marketwire - Dec 5, 2011) - Peregrine Pharmaceuticals, Inc. (NASDAQ: [ PPHM ]), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment of cancer and viral infections, today announced that it will report financial results for the second quarter of the fiscal year 2012 on December 12, 2011 after market and will host a conference call and webcast at 1:30 PM PST (4:30 PM EST). Peregrine's senior management will discuss financial results for the second quarter of fiscal year ended October 31, 2011 and will review progress of its clinical development programs.

  • To listen to the live webcast, or access the archived webcast, please visit: [ http://ir.peregrineinc.com/events.cfm ].

  • To listen to the conference call, please dial (877) 312-5443 or (253) 237-1126 and request the Peregrine Pharmaceuticals call. A replay of the call will be available starting approximately two hours after the conclusion of the call through December 26, 2011 by calling (855) 859-2056, or (404) 537-3406 and using passcode 28585204.

About Peregrine Pharmaceuticals
Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials for the treatment of cancer and serious viral infections. The company is pursuing multiple clinical programs in cancer and hepatitis C virus infection with its lead product candidate bavituximab and novel brain cancer agent Cotara®. Peregrine also has in-house cGMP manufacturing capabilities through its wholly-owned subsidiary Avid Bioservices, Inc. ([ www.avidbio.com ]), which provides development and biomanufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at [ www.peregrineinc.com ].



Publication Contributing Sources